Lower-limb MRI in the staging and re-staging of osteonecrosis in paediatric patients affected by acute lymphoblastic leukaemia after therapy

Skeletal Radiol. 2016 Apr;45(4):495-503. doi: 10.1007/s00256-016-2329-3. Epub 2016 Jan 19.

Abstract

Purpose: To assess the diagnostic value of MRI examination in detecting and monitoring osteonecrotic lesions (ON) in childhood acute lymphoblastic leukaemia (ALL) after chemotherapy (CHT) and/or bone marrow transplantation (BMT).

Methods and materials: Seventy-three patients (37 males, mean age 12.4 years old) with ALL after treatment underwent a lower-limb MR examination between November 2006 and March 2012. In 47 there was clinical suspicion of ON, 26 were asymptomatic. Studies were performed with a 1 T and a 1.5 T scanner, acquiring short tau inversion recovery (STIR) and T1-weighted sequences in coronal plane from the hips to the ankles. The average acquisition time was 18 min. Considering baseline and follow-up examinations, the overall number of MRI studies was 195.

Results: Fifty-four of 73 patients showed ON at MRI study, with an overall number of 323 ON (89 involving articular surface, 24 with joint deformity, JD). Twenty-five of 47 symptomatic patients showed subchondral ON lesions, 11 developed JD. Three of 26 asymptomatic patients showed subchondral bone ON at baseline examination but no JD at follow-up. Twenty-two of 28 BMT, 32/45 CHT patients developed ON.

Conclusion: Our MRI protocol proved to be feasible in evaluating ON in paediatric patients. Studies should be addressed only to symptomatic patients.

Keywords: Acute lymphoblastic leukaemia; MRI; Osteonecrosis.

MeSH terms

  • Bone Marrow Transplantation
  • Child
  • Female
  • Humans
  • Lower Extremity / diagnostic imaging*
  • Lower Extremity / pathology
  • Magnetic Resonance Imaging / methods*
  • Male
  • Osteonecrosis / diagnostic imaging*
  • Osteonecrosis / etiology*
  • Osteonecrosis / pathology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy